Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained its Buy rating on Encompass Health (NYSE:EHC) and raised the price target from $95 to $100.
July 15, 2024 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained its Buy rating on Encompass Health and raised the price target from $95 to $100.
The Buy rating and increased price target from a reputable analyst firm like Truist Securities is likely to positively impact investor sentiment and drive short-term price appreciation for Encompass Health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100